OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Scutellarin Ameliorates Renal Injury via Increasing CCN1 Expression and Suppressing NLRP3 Inflammasome Activation in Hyperuricemic Mice
Guozheng Li, Guan Chen, Lingyu Xu, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 33
Guozheng Li, Guan Chen, Lingyu Xu, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
Microalgae-based drug delivery microspheres for treatment of hyperuricemia with renal injury
Xiaoyang Liu, Jiajia Dong, Jiarong Cui, et al.
Nano Today (2025) Vol. 61, pp. 102607-102607
Closed Access | Times Cited: 2
Xiaoyang Liu, Jiajia Dong, Jiarong Cui, et al.
Nano Today (2025) Vol. 61, pp. 102607-102607
Closed Access | Times Cited: 2
Therapeutic potential and pharmacological mechanisms of Traditional Chinese Medicine in gout treatment
Jing-wen Guo, Guo‐Qiang Lin, Xinyi Tang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access | Times Cited: 2
Jing-wen Guo, Guo‐Qiang Lin, Xinyi Tang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access | Times Cited: 2
Breviscapine alleviates NASH by inhibiting TGF‐β‐activated kinase 1‐dependent signaling
Tian Lan, Shuo Jiang, Jing Zhang, et al.
Hepatology (2021) Vol. 76, Iss. 1, pp. 155-171
Open Access | Times Cited: 63
Tian Lan, Shuo Jiang, Jing Zhang, et al.
Hepatology (2021) Vol. 76, Iss. 1, pp. 155-171
Open Access | Times Cited: 63
Coptisine protects against hyperuricemic nephropathy through alleviating inflammation, oxidative stress and mitochondrial apoptosis via PI3K/Akt signaling pathway
Yanlu Liu, Shiting Gong, Kejian Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113941-113941
Open Access | Times Cited: 53
Yanlu Liu, Shiting Gong, Kejian Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113941-113941
Open Access | Times Cited: 53
Piperine Improves Hyperuricemic Nephropathy by Inhibiting URAT1/GLUT9 and the AKT-mTOR Pathway
Lu Li, Kunlu Zhao, Jian Luo, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 12, pp. 6565-6574
Closed Access | Times Cited: 13
Lu Li, Kunlu Zhao, Jian Luo, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 12, pp. 6565-6574
Closed Access | Times Cited: 13
Scutellarin alleviates renal ischemia–reperfusion injury by inhibiting the MAPK pathway and pro‐inflammatory macrophage polarization
Ge Deng, Bingxuan Zheng, Meng Dou, et al.
The FASEB Journal (2024) Vol. 38, Iss. 13
Open Access | Times Cited: 7
Ge Deng, Bingxuan Zheng, Meng Dou, et al.
The FASEB Journal (2024) Vol. 38, Iss. 13
Open Access | Times Cited: 7
Advances in Chemical Constituents, Clinical Applications, Pharmacology, Pharmacokinetics and Toxicology of Erigeron breviscapus
Ruixia Wu, Yan Jun Liang, Min Xu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 37
Ruixia Wu, Yan Jun Liang, Min Xu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 37
Isorhamnetin, the xanthine oxidase inhibitor fromSophora japonica, ameliorates uric acid levels and renal function in hyperuricemic mice
Fuqi Wang, Xu Zhao, Xin Su, et al.
Food & Function (2021) Vol. 12, Iss. 24, pp. 12503-12512
Closed Access | Times Cited: 35
Fuqi Wang, Xu Zhao, Xin Su, et al.
Food & Function (2021) Vol. 12, Iss. 24, pp. 12503-12512
Closed Access | Times Cited: 35
NLRP3 Inflammasome in Metabolic-Associated Kidney Diseases: An Update
Wei Xiong, Xianfang Meng, Chun Zhang
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 34
Wei Xiong, Xianfang Meng, Chun Zhang
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 34
TCM and related active compounds in the treatment of gout: the regulation of signaling pathway and urate transporter
Xin Sun, Le Yang, Hui Sun, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Xin Sun, Le Yang, Hui Sun, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Sanghuangporus vaninii ethanol extract alleviates hyperuricemic renal injury by regulating the uric acid transporters and inhibiting HK-2 apoptosis
Liping Hua, Shuangshuang Zhang, Jiali Yang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114970-114970
Open Access | Times Cited: 14
Liping Hua, Shuangshuang Zhang, Jiali Yang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114970-114970
Open Access | Times Cited: 14
Current advances on the therapeutic potential of scutellarin: an updated review
Yi-Fei Xie, Guotong Sun, Yue Tao, et al.
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Yi-Fei Xie, Guotong Sun, Yue Tao, et al.
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Baicalin Alleviates Contrast-Induced Acute Kidney Injury Through ROS/NLRP3/Caspase-1/GSDMD Pathway-Mediated Proptosis in vitro
Yanyan Li, Junda Wang, Dan Huang, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 3353-3364
Open Access | Times Cited: 20
Yanyan Li, Junda Wang, Dan Huang, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 3353-3364
Open Access | Times Cited: 20
Chloroquine inhibits NLRP3 inflammasomes activation and alleviates renal fibrosis in mouse model of hyperuricemic nephropathy with aggravation by a high-fat-diet
Jiong Cui, Pianpian Hong, Zhenzhou Li, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110353-110353
Closed Access | Times Cited: 13
Jiong Cui, Pianpian Hong, Zhenzhou Li, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110353-110353
Closed Access | Times Cited: 13
Regulatory Roles of Flavonoids in Caspase-11 Non-Canonical Inflammasome-Mediated Inflammatory Responses and Diseases
Young‐Su Yi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10402-10402
Open Access | Times Cited: 10
Young‐Su Yi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10402-10402
Open Access | Times Cited: 10
Amelioration of hyperuricemia by Lactobacillus acidophilus F02 with uric acid-lowering ability via modulation of NLRP3 inflammasome and gut microbiota homeostasis
Yingping Meng, Yingsheng Hu, Min Wei, et al.
Journal of Functional Foods (2023) Vol. 111, pp. 105903-105903
Open Access | Times Cited: 9
Yingping Meng, Yingsheng Hu, Min Wei, et al.
Journal of Functional Foods (2023) Vol. 111, pp. 105903-105903
Open Access | Times Cited: 9
Pharmacological effects and the related mechanism of scutellarin on inflammation-related diseases: a review
Yang Zhou, Chenlin Gu, Yan Zhu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Yang Zhou, Chenlin Gu, Yan Zhu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Scutellarin: pharmacological effects and therapeutic mechanisms in chronic diseases
Shanshan Nie, Shan Zhang, Ruipeng Wu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Shanshan Nie, Shan Zhang, Ruipeng Wu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives
Naiara Naiana Dejani, Hatem A. Elshabrawy, Carlos da Silva Maia Bezerra Filho, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1254-1254
Open Access | Times Cited: 20
Naiara Naiana Dejani, Hatem A. Elshabrawy, Carlos da Silva Maia Bezerra Filho, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1254-1254
Open Access | Times Cited: 20
Scutellarin Protects Against Mitochondrial Reactive Oxygen Species-Dependent NLRP3 Inflammasome Activation to Attenuate Intervertebral Disc Degeneration
Zihao Wang, Pengfei Zhang, Yunpeng Zhao, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 12
Zihao Wang, Pengfei Zhang, Yunpeng Zhao, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 12
Scutellarin ameliorates diabetic nephropathy via TGF-β1 signaling pathway
Bangrui Huang, Rui Han, Hong Tan, et al.
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Bangrui Huang, Rui Han, Hong Tan, et al.
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
The Role of Hyperuricemia in Cardiac Diseases: Evidence, Controversies, and Therapeutic Strategies
Yue Zheng, Z G Chen, JinHao Yang, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 753-753
Open Access | Times Cited: 2
Yue Zheng, Z G Chen, JinHao Yang, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 753-753
Open Access | Times Cited: 2
Scutellarein relieves the death and inflammation of tubular epithelial cells in ischemic kidney injury by degradation of COX-2 protein
Dong Liu, Cuijie Zhang, Min Hu, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108193-108193
Closed Access | Times Cited: 14
Dong Liu, Cuijie Zhang, Min Hu, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108193-108193
Closed Access | Times Cited: 14
Scutellarin protects the kidney from ischemia/reperfusion injury by targeting Nrf2
Jie Dai, Chenyu Li, Long Zhao, et al.
Nephrology (2022) Vol. 27, Iss. 8, pp. 690-700
Closed Access | Times Cited: 9
Jie Dai, Chenyu Li, Long Zhao, et al.
Nephrology (2022) Vol. 27, Iss. 8, pp. 690-700
Closed Access | Times Cited: 9
Scutellarin alleviates lipopolysaccharide-provoked septic nephrotoxicity via attenuation of inflammatory and oxidative events and mitochondrial dysfunction
Alireza Shahmohammadi, Ravieh Golchoobian, Seyed‐Mohamad‐Sadegh Mirahmadi, et al.
Immunopharmacology and Immunotoxicology (2022) Vol. 45, Iss. 3, pp. 295-303
Closed Access | Times Cited: 9
Alireza Shahmohammadi, Ravieh Golchoobian, Seyed‐Mohamad‐Sadegh Mirahmadi, et al.
Immunopharmacology and Immunotoxicology (2022) Vol. 45, Iss. 3, pp. 295-303
Closed Access | Times Cited: 9
